慢性乙型肝炎防治指南2010年更新版

被引:274
作者
机构
[1] 中华医学会感染病学分会
[2] 中华医学会肝病学分会
关键词
HBVDNA; 慢性乙型肝炎患者; HBsAg; 慢性乙型肝炎防治指南; 乙型肝炎病毒; 戴恩颗粒; HBeAg; 拉米夫定耐药; 核苷(酸)类似物; 2010;
D O I
暂无
中图分类号
R512.62 [];
学科分类号
100401 ;
摘要
为规范慢性乙型肝炎的预防、诊断和治疗,中华医学会肝病学分会和感染病学分会于2005年组织国内有关专家制订了《慢性乙型肝炎防治指南》[1]。近5年来,国内外有关慢性乙型肝炎的基础和临床研究取得很大进展,为此我们对本指南进行更新。本指南旨在帮助医生在慢性乙型肝炎诊疗和预防
引用
收藏
页码:79 / 100
页数:22
相关论文
共 53 条
[31]  
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study[J] . Yi-Cheng Chen,Chia-Ming Chu,Chau-Ting Yeh,Yun-Fan Liaw.Hepatology International . 2007 (1)
[32]  
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An Update[J] . Emmet B. Keeffe,Douglas T. Dieterich,Steven–Huy B. Han,Ira M. Jacobson,Paul Martin,Eugene R. Schiff,Hillel Tobias,Teresa L. Wright.Clinical Gastroenterology and Hepatology . 2006 (8)
[33]  
Kinetics and Risk of De Novo Hepatitis B Infection in HBsAg–Negative Patients Undergoing Cytotoxic Chemotherapy[J] . Chee–Kin Hui,Winnie W.W. Cheung,Hai–Ying Zhang,Wing–Yan Au,Yui–Hung Yueng,Anskar Y.H. Leung,Nancy Leung,John M. Luk,Albert K.W. Lie,Yok–Lam Kwong,Raymond Liang,George K.K. Lau.Gastroenterology . 2006 (1)
[34]  
Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B[J] . Morris Sherman,Cihan Yurdaydin,Jose Sollano,Marcelo Silva,Yun–Fan Liaw,Janusz Cianciara,Anna Boron–Kaczmarska,Paul Martin,Zachary Goodman,Richard Colonno,Anne Cross,Gail Denisky,Bruce Kreter,Robert Hindes.Gastroenterology . 2006 (7)
[35]   Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years [J].
Hadziyannis, Stephanos J. ;
Tassopoulos, Nicolaos C. ;
Heathcote, E. Jenny ;
Chang, Ting-Tsung ;
Kitis, George ;
Rizzetto, Mario ;
Marcellin, Patrick ;
Lik, Seng Gee ;
Goodman, Zachary ;
Ma, Jia ;
Brosgart, Carol L. ;
Eorroto-Esoda, Katyna ;
Arterburn, Sarah ;
Chuck, Steven L. .
GASTROENTEROLOGY, 2006, 131 (06) :1743-1751
[36]  
Hepatitis B Virus-Related Cirrhosis: Natural History and Treatment[J] . Chia-Ming Chu,Yun-Fan Liaw.Semin Liver Dis . 2006 (02)
[37]   Predicting cirrhosis risk based on the level of circulating hepatitis B viral load [J].
Iloeje, UH ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Chen, CJ .
GASTROENTEROLOGY, 2006, 130 (03) :678-686
[38]  
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents[J] . Eric E. Mast,Harold S. Margolis,Anthony E. Fiore,Edward W. Brink,Susan T. Goldstein,Susan A. Wang,Linda A. Moyer,Beth P. Bell,Miriam J. Alter.Morbidity and Mortality Weekly Report: Recommenda . 2005 (RR-1)
[39]  
Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study[J] . Alessandro Remo Zanetti,Andrea Mariano,Luisa Romanò,Raffaele D’Amelio,Maria Chironna,Rosa Cristina Coppola,Mario Cuccia,Rossana Mangione,Fosca Marrone,Francesco Saverio Negrone,Antonino Parlato,Emanuela Zamparo,Carla Zotti,Tommaso Stroffolini,Alfonso Mele.The Lancet . 2005 (9494)
[40]  
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline[J] . Chia-Ming Chu,Yun-Fan Liaw.Journal of Hepatology . 2005 (3)